ALVR - Class Action Lawsuit Filed Against AlloVir Inc. (ALVR) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer LLC Encourages Investors With Significant Losses to Contact the Firm | Benzinga

ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ:ALVR). The lawsuit alleges Defendants made materially false and misleading statements and/or failed to disclose material information regarding the Company's business, operations, and prospects, including allegations that: (i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the Company would ultimately discontinue the posoleucel Phase 3 studies; (iii) accordingly, AlloVir overstated the efficacy and clinical and/or ...

ALVR) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm>Full story available on Benzinga.com